The present study demonstrates that post-ischemic administration of tAUCB to block sEH exerts brain protection in non-diabetic mice, but fails to offer any neuroprotection in mice with type 2 diabetes (DM2), in a transient focal cerebral ischemia model. The gene discussed is EPHX2; the disease is type 2 diabetes mellitus.